(Q35570064)

8 August 2017

1 reference

title

3: Preventing complications of diabetes (English)

1 reference

8 August 2017

George Jerums

2

1 reference

8 August 2017

Katherine L. Bate

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583083

26 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

8 August 2017

3 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583083

full work available at URL

26 March 2024

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2003.tb05655.x

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

https://onlinelibrary.wiley.com/doi/full-xml/10.5694/j.1326-5377.2003.tb05655.x

26 March 2024

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Medical Journal of Australia

26 March 2024

published in

1 reference

8 August 2017

volume

179

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

498-503

1 reference

The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

26 March 2024

3

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

26 March 2024

4

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

26 March 2024

5

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

26 March 2024

7

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

26 March 2024

9

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

26 March 2024

10

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

26 March 2024

11

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Physical activity and risk for cardiovascular events in diabetic women

26 March 2024

13

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

26 March 2024

14

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol

26 March 2024

16

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Adherence to a Mediterranean diet and survival in a Greek population

26 March 2024

17

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes

26 March 2024

18

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

26 March 2024

20

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Standards of medical care for patients with diabetes mellitus

26 March 2024

21

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project

26 March 2024

23

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

26 March 2024

Diabetic retinopathy

24

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

26 March 2024

26

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

26 March 2024

27

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

26 March 2024

28

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

26 March 2024

29

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

26 March 2024

30

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study

26 March 2024

31

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05655.X

26 March 2024

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583083

26 March 2024

1 reference